 Myra Muramoto
Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 31 | 2026 | 440 | 4.710 |
Why?
| | Tobacco Use Cessation | 9 | 2017 | 29 | 3.130 |
Why?
| | Complementary Therapies | 7 | 2017 | 90 | 2.470 |
Why?
| | Tobacco Use Disorder | 12 | 2021 | 245 | 2.450 |
Why?
| | Massage | 6 | 2021 | 42 | 1.930 |
Why?
| | Smoking Prevention | 11 | 2021 | 184 | 1.850 |
Why?
| | Smoking | 20 | 2021 | 1603 | 1.640 |
Why?
| | Chiropractic | 4 | 2017 | 11 | 1.500 |
Why?
| | Secondary Prevention | 2 | 2026 | 241 | 1.490 |
Why?
| | Health Personnel | 9 | 2019 | 738 | 1.480 |
Why?
| | Family Practice | 4 | 2025 | 464 | 1.210 |
Why?
| | Acupuncture | 2 | 2015 | 2 | 0.930 |
Why?
| | Acupuncture Therapy | 5 | 2017 | 22 | 0.920 |
Why?
| | Oncologists | 1 | 2025 | 45 | 0.870 |
Why?
| | Physical Therapy Specialty | 2 | 2015 | 53 | 0.850 |
Why?
| | Physicians, Family | 2 | 2025 | 195 | 0.820 |
Why?
| | Smokers | 2 | 2021 | 144 | 0.770 |
Why?
| | Health Services Research | 1 | 2025 | 406 | 0.750 |
Why?
| | Mentoring | 1 | 2025 | 154 | 0.730 |
Why?
| | Advance Care Planning | 1 | 2025 | 223 | 0.710 |
Why?
| | Curriculum | 5 | 2015 | 1039 | 0.700 |
Why?
| | Education, Distance | 2 | 2021 | 56 | 0.690 |
Why?
| | Health Promotion | 6 | 2016 | 759 | 0.650 |
Why?
| | Motivation | 6 | 2017 | 603 | 0.620 |
Why?
| | Community Health Workers | 2 | 2011 | 76 | 0.600 |
Why?
| | Arizona | 7 | 2019 | 81 | 0.570 |
Why?
| | Biomedical Research | 1 | 2025 | 708 | 0.570 |
Why?
| | Nicotine | 7 | 2021 | 350 | 0.560 |
Why?
| | Behavior Therapy | 1 | 2021 | 282 | 0.560 |
Why?
| | Attitude of Health Personnel | 2 | 2025 | 1183 | 0.550 |
Why?
| | Bupropion | 4 | 2016 | 46 | 0.540 |
Why?
| | Leadership | 1 | 2021 | 399 | 0.510 |
Why?
| | Teaching Materials | 1 | 2016 | 24 | 0.510 |
Why?
| | Schools, Medical | 2 | 2015 | 152 | 0.500 |
Why?
| | Education, Continuing | 2 | 2016 | 41 | 0.500 |
Why?
| | Education, Medical, Undergraduate | 2 | 2015 | 196 | 0.480 |
Why?
| | Health Communication | 1 | 2016 | 48 | 0.480 |
Why?
| | Professional Practice | 1 | 2015 | 63 | 0.450 |
Why?
| | Delivery of Health Care | 3 | 2021 | 962 | 0.450 |
Why?
| | Patients | 1 | 2016 | 180 | 0.440 |
Why?
| | Self Efficacy | 3 | 2014 | 408 | 0.440 |
Why?
| | Substance-Related Disorders | 2 | 2021 | 1102 | 0.430 |
Why?
| | Skin Neoplasms | 1 | 2021 | 857 | 0.420 |
Why?
| | Humans | 56 | 2026 | 141754 | 0.390 |
Why?
| | Developing Countries | 3 | 2015 | 318 | 0.370 |
Why?
| | Adult | 26 | 2026 | 39391 | 0.370 |
Why?
| | Interviews as Topic | 3 | 2025 | 854 | 0.360 |
Why?
| | Teaching | 1 | 2014 | 237 | 0.360 |
Why?
| | Female | 36 | 2026 | 75943 | 0.350 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2014 | 1406 | 0.340 |
Why?
| | Program Development | 2 | 2019 | 368 | 0.340 |
Why?
| | Male | 31 | 2026 | 70179 | 0.330 |
Why?
| | Health Education | 3 | 2010 | 364 | 0.330 |
Why?
| | Recurrence | 2 | 2026 | 1111 | 0.320 |
Why?
| | Indians, North American | 1 | 2015 | 655 | 0.310 |
Why?
| | Neoplasms | 1 | 2025 | 2747 | 0.310 |
Why?
| | Social Support | 4 | 2010 | 633 | 0.310 |
Why?
| | Inservice Training | 1 | 2010 | 122 | 0.300 |
Why?
| | Couples Therapy | 2 | 2006 | 13 | 0.290 |
Why?
| | Alcohol Drinking | 1 | 2015 | 835 | 0.290 |
Why?
| | Drug and Narcotic Control | 1 | 2008 | 29 | 0.280 |
Why?
| | Law Enforcement | 1 | 2008 | 46 | 0.270 |
Why?
| | Decision Making | 2 | 2021 | 961 | 0.270 |
Why?
| | Amphetamine-Related Disorders | 1 | 2008 | 45 | 0.270 |
Why?
| | Breast Feeding | 2 | 2008 | 444 | 0.270 |
Why?
| | Education | 2 | 2014 | 109 | 0.270 |
Why?
| | Qualitative Research | 4 | 2025 | 1547 | 0.270 |
Why?
| | Methamphetamine | 1 | 2008 | 67 | 0.270 |
Why?
| | Occupational Health | 1 | 2010 | 208 | 0.260 |
Why?
| | Faculty, Medical | 2 | 2009 | 296 | 0.260 |
Why?
| | Professional-Patient Relations | 1 | 2008 | 151 | 0.260 |
Why?
| | Middle Aged | 15 | 2025 | 34647 | 0.250 |
Why?
| | Risk Reduction Behavior | 1 | 2008 | 227 | 0.250 |
Why?
| | Referral and Consultation | 3 | 2010 | 799 | 0.250 |
Why?
| | Central Nervous System Stimulants | 1 | 2008 | 178 | 0.250 |
Why?
| | Manipulation, Chiropractic | 2 | 2016 | 4 | 0.240 |
Why?
| | Postpartum Period | 1 | 2008 | 354 | 0.230 |
Why?
| | Primary Health Care | 4 | 2025 | 1809 | 0.230 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2026 | 127 | 0.230 |
Why?
| | United States | 9 | 2021 | 15310 | 0.220 |
Why?
| | Coronary Disease | 1 | 2006 | 371 | 0.210 |
Why?
| | Feedback | 2 | 2021 | 179 | 0.200 |
Why?
| | Program Evaluation | 3 | 2019 | 930 | 0.190 |
Why?
| | Young Adult | 8 | 2017 | 13749 | 0.180 |
Why?
| | Mothers | 1 | 2008 | 785 | 0.180 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 2021 | 39 | 0.180 |
Why?
| | Nicotinic Agonists | 1 | 2003 | 136 | 0.180 |
Why?
| | Indonesia | 4 | 2015 | 23 | 0.180 |
Why?
| | Focus Groups | 3 | 2016 | 572 | 0.180 |
Why?
| | Substance Withdrawal Syndrome | 2 | 2003 | 185 | 0.170 |
Why?
| | Physician-Patient Relations | 2 | 2025 | 585 | 0.170 |
Why?
| | Health Behavior | 2 | 2021 | 792 | 0.170 |
Why?
| | Patient Education as Topic | 4 | 2010 | 779 | 0.170 |
Why?
| | Community Health Services | 2 | 2010 | 233 | 0.160 |
Why?
| | Surveys and Questionnaires | 4 | 2019 | 5974 | 0.160 |
Why?
| | Adolescent | 14 | 2017 | 22130 | 0.160 |
Why?
| | Longitudinal Studies | 4 | 2010 | 2938 | 0.160 |
Why?
| | Certification | 1 | 2000 | 119 | 0.150 |
Why?
| | Forecasting | 1 | 2021 | 384 | 0.150 |
Why?
| | Health Surveys | 4 | 2015 | 513 | 0.150 |
Why?
| | Personal Satisfaction | 1 | 2021 | 215 | 0.150 |
Why?
| | Psychotherapy, Group | 1 | 2019 | 74 | 0.150 |
Why?
| | Reagent Strips | 1 | 1999 | 8 | 0.150 |
Why?
| | Guidelines as Topic | 1 | 2000 | 275 | 0.150 |
Why?
| | Communication | 1 | 2025 | 951 | 0.140 |
Why?
| | Research Design | 2 | 2015 | 1146 | 0.140 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2006 | 1048 | 0.140 |
Why?
| | Feasibility Studies | 2 | 2021 | 1027 | 0.140 |
Why?
| | Tobacco Products | 2 | 2014 | 98 | 0.140 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 2017 | 29 | 0.130 |
Why?
| | Substance Abuse Detection | 1 | 1999 | 105 | 0.130 |
Why?
| | Evidence-Based Medicine | 2 | 2003 | 750 | 0.130 |
Why?
| | Evaluation Studies as Topic | 1 | 2017 | 175 | 0.130 |
Why?
| | Computer Simulation | 1 | 2021 | 1015 | 0.130 |
Why?
| | Contraception Behavior | 1 | 2017 | 102 | 0.130 |
Why?
| | Psychiatry | 1 | 2019 | 188 | 0.130 |
Why?
| | Hospitals | 1 | 2021 | 696 | 0.130 |
Why?
| | Aged | 7 | 2016 | 24746 | 0.120 |
Why?
| | Follow-Up Studies | 4 | 2011 | 5212 | 0.120 |
Why?
| | Alcohol Abstinence | 1 | 2015 | 13 | 0.120 |
Why?
| | Cell Phone | 1 | 2016 | 82 | 0.120 |
Why?
| | Cross-Sectional Studies | 8 | 2017 | 5697 | 0.120 |
Why?
| | Binge Drinking | 1 | 2015 | 46 | 0.120 |
Why?
| | Mental Health Services | 1 | 2019 | 447 | 0.110 |
Why?
| | Health Priorities | 2 | 2015 | 44 | 0.110 |
Why?
| | Mobile Applications | 1 | 2016 | 185 | 0.100 |
Why?
| | Tobacco Smoke Pollution | 4 | 2015 | 256 | 0.100 |
Why?
| | Minority Groups | 1 | 2015 | 278 | 0.100 |
Why?
| | Poverty | 2 | 2008 | 530 | 0.100 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2015 | 105 | 0.100 |
Why?
| | Patient Compliance | 2 | 2008 | 611 | 0.100 |
Why?
| | Counseling | 3 | 2019 | 398 | 0.100 |
Why?
| | Psychotropic Drugs | 1 | 1993 | 75 | 0.090 |
Why?
| | Medication Adherence | 1 | 2016 | 513 | 0.090 |
Why?
| | Pregnancy Complications, Hematologic | 1 | 2012 | 25 | 0.090 |
Why?
| | Drug Monitoring | 1 | 2015 | 399 | 0.090 |
Why?
| | Southwestern United States | 2 | 2008 | 94 | 0.090 |
Why?
| | Pilot Projects | 3 | 2015 | 1826 | 0.090 |
Why?
| | Anemia | 1 | 2012 | 177 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2015 | 587 | 0.080 |
Why?
| | Double-Blind Method | 3 | 2016 | 1989 | 0.080 |
Why?
| | International Cooperation | 1 | 2010 | 203 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2016 | 1570 | 0.080 |
Why?
| | Interpersonal Relations | 3 | 2010 | 411 | 0.070 |
Why?
| | User-Computer Interface | 1 | 2010 | 164 | 0.070 |
Why?
| | Maternal-Child Health Centers | 1 | 2008 | 9 | 0.070 |
Why?
| | Education, Public Health Professional | 1 | 2008 | 8 | 0.070 |
Why?
| | Delayed-Action Preparations | 2 | 2007 | 177 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2016 | 2064 | 0.070 |
Why?
| | Diabetes Complications | 1 | 2010 | 224 | 0.070 |
Why?
| | Drug Administration Routes | 1 | 2008 | 41 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 248 | 0.070 |
Why?
| | Substance Abuse Treatment Centers | 1 | 2008 | 47 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3356 | 0.070 |
Why?
| | Telemedicine | 1 | 2016 | 894 | 0.070 |
Why?
| | Body Mass Index | 1 | 2016 | 2385 | 0.070 |
Why?
| | Education, Medical | 1 | 2010 | 271 | 0.060 |
Why?
| | Data Collection | 1 | 2010 | 662 | 0.060 |
Why?
| | Systems Theory | 1 | 2006 | 4 | 0.060 |
Why?
| | Home Care Services | 1 | 2010 | 261 | 0.060 |
Why?
| | Ganglionic Stimulants | 1 | 2006 | 15 | 0.060 |
Why?
| | California | 1 | 2008 | 466 | 0.060 |
Why?
| | Milk, Human | 1 | 2008 | 169 | 0.060 |
Why?
| | India | 3 | 2015 | 208 | 0.060 |
Why?
| | Social Class | 1 | 2008 | 268 | 0.060 |
Why?
| | Women's Health | 1 | 2008 | 311 | 0.060 |
Why?
| | Alcoholism | 1 | 1993 | 823 | 0.060 |
Why?
| | Universities | 1 | 2008 | 454 | 0.060 |
Why?
| | Cooperative Behavior | 1 | 2008 | 463 | 0.060 |
Why?
| | Problem Solving | 1 | 2006 | 156 | 0.060 |
Why?
| | Internet | 1 | 2010 | 690 | 0.060 |
Why?
| | Child Behavior | 1 | 2006 | 251 | 0.050 |
Why?
| | Pediatrics | 2 | 2010 | 1100 | 0.050 |
Why?
| | Nonprescription Drugs | 1 | 2004 | 66 | 0.050 |
Why?
| | Weight Loss | 1 | 2008 | 791 | 0.050 |
Why?
| | Attitude to Health | 1 | 2006 | 458 | 0.050 |
Why?
| | Socioeconomic Factors | 3 | 2014 | 1317 | 0.050 |
Why?
| | Feces | 2 | 2012 | 505 | 0.050 |
Why?
| | Pregnancy | 3 | 2012 | 7092 | 0.040 |
Why?
| | Adolescent Behavior | 1 | 2006 | 538 | 0.040 |
Why?
| | Adaptation, Psychological | 1 | 2006 | 681 | 0.040 |
Why?
| | Administration, Oral | 1 | 2003 | 803 | 0.040 |
Why?
| | Global Health | 3 | 2010 | 387 | 0.040 |
Why?
| | Prevalence | 3 | 2017 | 2799 | 0.040 |
Why?
| | False Negative Reactions | 1 | 1999 | 61 | 0.040 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 1999 | 50 | 0.040 |
Why?
| | Encephalitozoon | 1 | 1998 | 2 | 0.040 |
Why?
| | Encephalitozoonosis | 1 | 1998 | 2 | 0.040 |
Why?
| | Observer Variation | 1 | 1999 | 357 | 0.030 |
Why?
| | Time Factors | 1 | 2008 | 6966 | 0.030 |
Why?
| | Child | 2 | 2015 | 22414 | 0.030 |
Why?
| | Parents | 1 | 2005 | 1440 | 0.030 |
Why?
| | Health Status | 2 | 2012 | 824 | 0.030 |
Why?
| | Placebos | 1 | 2016 | 198 | 0.030 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2015 | 60 | 0.030 |
Why?
| | Education, Nonprofessional | 1 | 2015 | 10 | 0.030 |
Why?
| | Prospective Studies | 1 | 2007 | 7777 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2007 | 2096 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2003 | 2903 | 0.030 |
Why?
| | Models, Educational | 1 | 2015 | 95 | 0.030 |
Why?
| | Administration, Inhalation | 2 | 2006 | 594 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2567 | 0.030 |
Why?
| | Child of Impaired Parents | 1 | 1993 | 41 | 0.020 |
Why?
| | Hookworm Infections | 1 | 2012 | 3 | 0.020 |
Why?
| | Nepal | 1 | 2012 | 31 | 0.020 |
Why?
| | Body Weights and Measures | 1 | 2012 | 36 | 0.020 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2012 | 9 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2016 | 697 | 0.020 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2012 | 60 | 0.020 |
Why?
| | Social Environment | 1 | 1993 | 295 | 0.020 |
Why?
| | Overweight | 1 | 2016 | 588 | 0.020 |
Why?
| | Mass Media | 1 | 2010 | 45 | 0.020 |
Why?
| | Community-Institutional Relations | 1 | 2010 | 102 | 0.020 |
Why?
| | Rural Population | 2 | 2008 | 606 | 0.020 |
Why?
| | Cultural Competency | 1 | 2010 | 94 | 0.020 |
Why?
| | Northwestern United States | 1 | 2008 | 57 | 0.020 |
Why?
| | Pediatric Obesity | 1 | 2016 | 601 | 0.020 |
Why?
| | Risk Factors | 2 | 2012 | 10482 | 0.020 |
Why?
| | Patient Care Team | 1 | 1993 | 673 | 0.020 |
Why?
| | Anthropology, Cultural | 1 | 2006 | 21 | 0.020 |
Why?
| | Societies, Scientific | 1 | 2006 | 51 | 0.020 |
Why?
| | Harm Reduction | 1 | 2006 | 39 | 0.020 |
Why?
| | Carbon Monoxide | 1 | 2006 | 83 | 0.020 |
Why?
| | Family | 1 | 2010 | 680 | 0.010 |
Why?
| | Morals | 1 | 2006 | 78 | 0.010 |
Why?
| | Research Support as Topic | 1 | 2006 | 121 | 0.010 |
Why?
| | Physician's Role | 1 | 2006 | 219 | 0.010 |
Why?
| | Students, Nursing | 1 | 2006 | 92 | 0.010 |
Why?
| | Diet | 1 | 2012 | 1282 | 0.010 |
Why?
| | Health Planning Guidelines | 1 | 2003 | 25 | 0.010 |
Why?
| | Public Health | 1 | 2006 | 587 | 0.010 |
Why?
| | Sex Factors | 1 | 2007 | 2063 | 0.010 |
Why?
| | Students, Medical | 1 | 2006 | 369 | 0.010 |
Why?
| | Administration, Cutaneous | 1 | 1999 | 129 | 0.010 |
Why?
| | Physicians | 1 | 2007 | 942 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2003 | 1057 | 0.010 |
Why?
| | Mexico | 1 | 1998 | 232 | 0.010 |
Why?
| | Water Supply | 1 | 1998 | 86 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 1998 | 386 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 1999 | 1041 | 0.010 |
Why?
| | Weight Gain | 1 | 1999 | 539 | 0.010 |
Why?
| | Quality of Life | 1 | 2006 | 3014 | 0.010 |
Why?
| | Child, Preschool | 1 | 2008 | 11512 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2006 | 11181 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1998 | 1474 | 0.010 |
Why?
| | Animals | 1 | 1998 | 37749 | 0.000 |
Why?
|
|
Muramoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|